Advanced Search
Feed
Contact Us
Login
Register
Login
Register
Feed
Contact Us
Invite People
Share 4Engineers with your friends and help them get started!
Emails
Enter multiple email addresses by separating it with a comma.
Send Invite
Advanced Search
Back
4Engineers
· Manufacturing Industry News and eMagazine - Recent News
Multiply Labs Announces New Collaboration to Automate Cell Therapy Manufacturing with Robotics
This article was originally posted on manufacturingtomorrow.com.
View article ->
Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology
1
0 followers
Login to comment
Login
Related Conversations
Molecular Devices Expands Access to Automated, AI-Ready Research Solutions Through Partnership with Automata's LINQ Platform
0 Replies
COMAU and OMRON Robotics to collaborate on expanding advanced industrial automation solutions across light industry, electronics, and medical manufacturing
0 Replies
Roboticom Announces New Distribution and Innovation Partnership with Forged Path Automation
0 Replies
ABB Robotics launches new automated surface finishing cell
0 Replies
Quintus Technologies and Lyric Robot Form Strategic Collaboration to Accelerate Industrialization of Solid-State Battery Production
0 Replies
Recent Conversations
Test
0 Replies
Test
0 Replies
Test
0 Replies
Test Discussion
0 Replies
Test Discussion
0 Replies
Your Conversations
Engineering Students Design, Fabricate, and Build Real Steel Bridges
0 Replies
My Old Table Saw Is Better Than My SawStop… Except for One Thing
0 Replies
EWB-USA Restructures Global Partnerships to Build Local Capacity, Not Just Local Projects
0 Replies
Toray Industries wins RO membrane order for Singapore’s Changi NEWater Factory
0 Replies
Insight Works Adds Three Business Central Partners, From a Microsoft MVP to a German Energy Manufacturer
0 Replies
Report content
Reason
Harassment or bullying
Discrimination or hate speech
Unprofessional behaviour
Doxxing or sharing personal information
Off-topic
Low-quality content
Misinformation
Duplicate content
Spam or self-promotion
Phishing or scams
Copyright or licensing violations
Confidentiality violations
Illegal content
Description
Submit